Could cannabis ease opioid withdrawal? new study aims to find out
NCT ID NCT07661446
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test whether cannabis can reduce the severity of opioid withdrawal and make opioid use safer. One hundred adults with opioid use disorder will live in a hospital for about six weeks. Researchers will give them cannabis and a small dose of opioids to see how their bodies react. The goal is to understand if cannabis can help manage withdrawal symptoms and reduce the risks of opioid use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Inhaled cannabis
What this could lead to
If it works, this could point toward a way to use cannabis to help manage opioid withdrawal and reduce the risks of opioid use.
What could go wrong
This is a very early Phase 1 study with only 100 people. It is designed to test safety and basic effects, not to prove a treatment works. The results may not lead to a new therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANNABIS USE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Kentucky
Lexington, Kentucky, 40508, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact